abstract |
The present invention inhibits JAK and SYK, and is useful for the treatment of autoimmune diseases and inflammatory diseases. Formula (I) [wherein the variable groups Q and R 1 and R 2 are defined herein. As defined] to the use of novel pyrrolopyrazine derivatives. |